Pharmabiz2m
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced its first reimbursement payment from ...
Pharmabiz1h
Biogen begins TRANSCEND phase 3 study of felzartamab to treat late antibody-mediated rejection in kidney transplant patients
Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...
Pharmabiz18h
Aakash Healthcare in association with ANVKA Foundation launches nationwide initiative to transform lives of children with bone deformities
Our Bureau, Mumbai Wednesday, March 12, 2025, 16:45 Hrs [IST] ...
Pharmabiz3h
DGFT seeks industry feedback on proposed amendments to "stock and sale" export authorization for SCOMET items
DGFT seeks industry feedback on proposed amendments to "stock and sale" export authorization for SCOMET items: Shardul Nautiyal, Mumbai Thursday, March 13, 2025, 08:00 Hrs [IST] T ...
Pharmabiz3h
ICMR boosts aviation medicine with its new Centre for Advanced Research on Space Psychology
ICMR boosts aviation medicine with its new Centre for Advanced Research on Space Psychology: Nandita Vijayasimha Bengaluru Thursday, March 13, 2025, 08:00 Hrs [IST] The Indian Cou ...
Pharmabiz3h
Panel raises concern over regulatory roadblocks affecting medical devices sector
Panel raises concern over regulatory roadblocks affecting medical devices sector: Gireesh Babu, New Delhi Thursday, March 13, 2025, 08:00 Hrs [IST] The delays and lack of transpar ...
Pharmabiz3h
Counterfeit drugs reach market due to grey marketing companies’ involvement: Bihar DC
Counterfeit drugs reach market due to grey marketing companies’ involvement: Bihar DC: Peethaambaran Kunnathoor, Chennai Thursday, March 13, 2025, 08:00 Hrs [IST] The present co ...
Pharmabiz3h
Adapt risk-based approach in export approvals, says expert
Our Bureau, New Delhi Thursday, March 13, 2025, 08:00 Hrs [IST] The drug regulators may look at adapting a risk-based a ...
Pharmabiz20h
Caristo Diagnostics’ CaRi-Plaque technology, an AI-assisted image analysis application to aid the diagnosis of CAD receives US FDA 510(k) clearance
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
Pharmabiz22h
Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients
Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients: Princeton, New Jersey Wednesday, March 12, 2025, ...
Pharmabiz17h
Hudson Therapeutics announces Shaperon to initiate phase 2b part 2 clinical trial of a topically administered drug, NuGel
Cambridge, Massachusetts Wednesday, March 12, 2025, 18:00 Hrs [IST] ...
Pharmabiz18h
Alkem Labs launches generic empagliflozin and its combinations in India under the brand name “Empanorm”
Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...